MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 597642 | Name: Levomoprolol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Levomoprolol is a beta adrenergic antagonist. It is the (S)-enantiomer of moprolol.

Chemical Structure

Levomoprolol
CAS#77164-20-6

Theoretical Analysis

MedKoo Cat#: 597642

Name: Levomoprolol

CAS#: 77164-20-6

Chemical Formula: C13H21NO3

Exact Mass: 239.1521

Molecular Weight: 239.32

Elemental Analysis: C, 65.25; H, 8.85; N, 5.85; O, 20.06

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
113482-87-4 (HCl) 77164-20-6 (free base)
Synonym
Levomoprolol; l-Moprolol; Levomoprololum;
IUPAC/Chemical Name
(S)-1-(isopropylamino)-3-(2-methoxyphenoxy)propan-2-ol
InChi Key
LFTFGCDECFPSQD-NSHDSACASA-N
InChi Code
InChI=1S/C13H21NO3/c1-10(2)14-8-11(15)9-17-13-7-5-4-6-12(13)16-3/h4-7,10-11,14-15H,8-9H2,1-3H3/t11-/m0/s1
SMILES Code
O[C@H](COC1=CC=CC=C1OC)CNC(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Product Data
Instruction
View handling instruction
Biological target:
Levomoprolol is a beta adrenergic antagonist. It is the (S)-enantiomer of moprolol.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 239.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Ghosh S, Bhaumik J, Banoth L, Banesh S, Banerjee UC. Chemoenzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker. Chirality. 2016 Apr;28(4):313-8. doi: 10.1002/chir.22574. Epub 2016 Jan 28. PubMed PMID: 26821612. 2: Gianesello V, Brenn E, Figini G, Gazzaniga A. Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration. J Chromatogr. 1989 Jul 7;473(2):343-52. PubMed PMID: 2570078. 3: Pecori-Giraldi J, Virno M, Ciarnella A, Taverniti L. [The beta-blocker levomoprolol in the treatment of glaucoma]. Bull Mem Soc Fr Ophtalmol. 1985;96:433-6. French. PubMed PMID: 2861871. 4: Santambrogio R, Opocher E, Galeotti F, Montorsi M, Cucchiaro G, Gagliano G, Spina GP. [The hemodynamic effects on the portal system of levomoprolol and propranolol in rats with an enhanced adrenergic tonus]. Minerva Med. 1989 Aug;80(8):949-51. Italian. PubMed PMID: 2571957. 5: Lai C, Tallu B, Onnis E, Pirisi R, Cioglia G, Cherchi A. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris]. Cardiologia. 1984 Dec;29(12):605-14. Italian. PubMed PMID: 6152549. 6: Pecori-Giraldi J, Virno M, Ralli R, Planner-Terzaghi A. [Long-term treatment of wide-angle glaucoma with the beta blocker levomoprolol: therapeutic effectiveness without side effects]. Fortschr Ophthalmol. 1986;83(5):564-6. German. PubMed PMID: 2878862. 7: Rossetti L, Barbieri P, Velati P, Bujtar E, Orzalesi N. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1994 Nov;232(11):670-4. PubMed PMID: 7843592. 8: Alinovi A, Branchetti A, Barella PA. [Iatrogenic dermatoses caused by beta-blocking drugs]. G Ital Dermatol Venereol. 1983 Nov-Dec;118(6):341-8. Review. Italian. PubMed PMID: 6143722. 9: Duclos J, Kussaibi H, Pacault V, Roussel H, Sandid W, Janin A, Bertheau P. [A case of giant cell microscopic colitis?]. Ann Pathol. 2008 Dec;28(6):501-3. doi: 10.1016/j.annpat.2008.09.045. Epub 2008 Nov 17. French. PubMed PMID: 19084720. 10: White JD, Shaw S. A new catalyst for the asymmetric Henry reaction: synthesis of β-nitroethanols in high enantiomeric excess. Org Lett. 2012 Dec 21;14(24):6270-3. doi: 10.1021/ol3030023. Epub 2012 Nov 30. PubMed PMID: 23194499. 11: Harvengt C, Desager JP. The pharmacokinetics of dl- and l-moprolol in the human. Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):57-61. PubMed PMID: 6120901. 12: Triulzi MO, Balice G, Gentile F, Rossini GL, Fattori CM. Tolerability of high doses of (-)-moprolol in healthy volunteers. Eur J Clin Pharmacol. 1982;22(4):377-8. PubMed PMID: 6125397. 13: Ghirardi P, Grosso F. Antihypertensive activity of (-) moprolol in man: double-blind comparison of enantiomers. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):471-2. PubMed PMID: 6156344. 14: Merlo L, Brusoni B, Mussini E, Ghirardi P. [The cardiovascular effects of the optical isomers of 1-(0-methoxy-phenoxy-)-3-isopropylamino-2-propanolo-hydrochloride (moprolol)]. Boll Soc Ital Cardiol. 1980;25(8):955-61. Italian. PubMed PMID: 6116496. 15: el-Ashmawy MB, Lissavetzky J, Darias V, Martín-Herrera D. Synthesis and pharmacological study of a thiophene analogue of moprolol and related compounds. Arch Pharm (Weinheim). 1991 Jan;324(1):45-8. PubMed PMID: 1675047. 16: Li F, Bi H, Côté M, Cooper S. Identification and determination of the enantiomers of moprolol and their metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr. 1993 Dec 22;622(2):187-95. PubMed PMID: 7908669. 17: Porciatti F, Cerbai E, Masini I, Mugelli A. Electrophysiological evaluation of the beta-blocking properties and direct membrane effects of l-moprolol and its enantiomer d-moprolol. Arch Int Pharmacodyn Ther. 1989 May-Jun;299:200-9. PubMed PMID: 2570555. 18: Santambrogio R, Galeotti F, Opocher E, Cucchiaro G, Cornalba GP, Rota L, Ferrario M, Fumagalli U, Spina GP. [Role of beta blockers in preventing hemorrhages from esophageal varices. A hemodynamic study]. Minerva Med. 1986 Mar 24;77(12):429-32. Italian. PubMed PMID: 2871526. 19: De Ambroggi L, Perotta GM, Satolli R, Lotto A. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct]. Boll Soc Ital Cardiol. 1977;22(8):1343-51. Italian. PubMed PMID: 36116.